Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BIAF
BIAF logo

BIAF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy bioAffinity Technologies Inc (BIAF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.830
1 Day change
2.72%
52 Week Range
13.800
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BIAF is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock lacks supportive fundamentals, has no recent positive news or catalyst, and its chart is still structurally weak despite a small positive MACD shift. With no strong Intellectia buy signal and no evidence of meaningful institutional, insider, or congress buying, the better decision is to wait rather than buy now.

Technical Analysis

Current price is around 0.83, essentially flat versus the prior close, with a small pre-market bounce and slight post-market improvement, but the regular session was down 1.60%. MACD histogram is positive and expanding, which is a mild short-term improvement. However, RSI_6 at 27.576 suggests the stock is oversold/weak rather than in a strong uptrend. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which confirms the broader trend is still negative. Pivot support is 0.827, with S1 at 0.792 and S2 at 0.771, while resistance sits at 0.861 and 0.882. Overall, the technical setup is weak and not supportive of an immediate long-term entry.

Positive Catalysts

  • No news in the recent week. No significant hedge fund buying trends. No meaningful insider accumulation. No recent congress trading data. The only mildly positive point is the expanding positive MACD histogram, which may indicate short-term stabilization.

Neutral/Negative Catalysts

  • No recent news-driven catalyst. Hedge funds are neutral and insiders are neutral, showing no clear conviction from informed market participants. The stock traded lower during the regular session. The broader moving average structure is bearish. AI Stock Picker shows no signal, and SwingMax shows no recent signal. Congress trading data is unavailable, so there is no political buying support. The company also has no usable financial snapshot in the provided data, limiting confidence further.

Financial Performance

No reliable latest-quarter financial snapshot was available because the provided financial data returned an error. As a result, there is no confirmed evidence of recent revenue or earnings growth trends for the latest quarter season. For a beginner long-term investor, this lack of financial clarity is a major drawback.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade/downgrade trend to support the stock. Based on the available information, Wall Street pros would likely have a cautious view: the positives are limited to a slight technical rebound signal, while the negatives include bearish moving averages, no recent catalysts, no signal from Intellectia tools, and no supportive institutional or insider activity.

Wall Street analysts forecast BIAF stock price to rise
Analyst Rating
0
Wall Street analysts forecast BIAF stock price to rise
Buy
Hold
Sell
0
Current: 0.808
sliders
Low
0
Averages
0
High
0
0
Current: 0.808
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch